Synovion Laboratories Pvt Ltd
Isotretinoin (20mg)
Popout 20mg Capsule is a retinoid (vitamin A derivative) used to treat severe acne that has not responded to other treatments.
Capsule
Popout 20mg Capsule should be used in the dose and duration as advised by your doctor. Take it with food, preferably at the same time each day to avoid a missed dose. It may take several weeks for your symptoms to improve but keep taking the medicine regularly to get the most benefit. If you notice no improvement after a few weeks, see your doctor again.
Take this medicine in the dose and duration as advised by your doctor. Popout 20mg Capsule is to be taken with food.
Popout 20mg Capsule is a derivative of vitamin A. It acts on glands (sebaceous) to reduce the production of a natural substance (sebum) that causes acne. Also, the controlled sebum production kills acne-causing bacteria. It also works as an anti-inflammatory to decrease inflammation (redness and swelling).
You have been prescribed Popout 20mg Capsule for the treatment of severe acne. Take it with food. Avoid exposure to sunlight while using Popout 20mg Capsule. Use protective measures such as sunscreen or protective clothing. Avoid face waxing and laser treatment while using this medicine as it makes your skin more fragile. It may cause dryness of mouth, lips, and eyes. Drink plenty of water, use moisturiser, and avoid wearing contact lenses. Inform your doctor if it bothers you. Do not take Popout 20mg Capsule if you are pregnant, planning pregnancy, or breastfeeding.
Popout 20mg Capsule should be used with caution as it is associated with significant adverse reactions. It should only be taken by patients with severe nodular acne who are unresponsive to conventional therapies, including systemic antibiotics. Furthermore, Popout 20mg Capsule should not be used by pregnant women due to the high risk of serious birth defects.
No, Popout 20mg Capsule is a retinoid (vitamin A) that treats severe acne.
Before starting treatment, your liver enzymes and serum lipids will be checked. These levels will also be monitored 1 month after the start of treatment and subsequently at 3-month intervals unless more frequent monitoring is clinically indicated.
A single 15-20-week course has been shown to effectively treat acne and prevent its recurrence in most patients. However, if a second course is required, it should be initiated at least 8 weeks after completion of the first course. This is because experience with Popout 20mg Capsule indicates that symptoms may continue to improve following treatment.
Using Popout 20mg Capsule while pregnant poses a serious risk of birth defects in the fetus. This is because the drug can cross the placenta, leading to severe abnormalities.
There are no documented reports of Popout 20mg Capsule causing cancer. In fact, it may have a protective effect in certain forms of head, skin, and neck cancers.
A standard course of treatment with Popout 20mg Capsule is 15–20 weeks. Long-term effects from low doses have not been extensively studied. However, it may negatively impact bone mineral density, potentially leading to osteoporosis or fractures in some patients.
No, Popout 20mg Capsule does not appear to adversely affect male fertility. It did not show any significant effects on ejaculate volume, sperm count, total sperm motility, morphology, or seminal plasma fructose.
It is possible to experience a temporary increase in liver enzymes while using Popout 20mg Capsule. Regular laboratory monitoring is necessary. If these levels remain elevated for a prolonged time, your doctor may discontinue Popout 20mg Capsule usage.